129 related articles for article (PubMed ID: 27995372)
1. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
Jia H; Zhang Q; Liu F; Zhou D
Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372
[TBL] [Abstract][Full Text] [Related]
2. Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.
Liu C
Clin Exp Med; 2016 Aug; 16(3):375-82. PubMed ID: 26123901
[TBL] [Abstract][Full Text] [Related]
3. The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer.
Fu Z; Xu S; Xu Y; Ma J; Li J; Xu P
Int J Gynecol Cancer; 2015 Mar; 25(3):356-62. PubMed ID: 25695542
[TBL] [Abstract][Full Text] [Related]
4. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer.
Vos MC; van der Wurff AA; Bulten J; Kruitwagen R; Feijen H; van Kuppevelt TH; Hendriks T; Massuger LF
Diagn Pathol; 2016 Apr; 11():34. PubMed ID: 27038607
[TBL] [Abstract][Full Text] [Related]
5. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
Kuşku Cabuk F; Yığıt S; Demır L; Cakalağaoğlu F; Tarhan O
Turk Patoloji Derg; 2014; 30(1):30-7. PubMed ID: 24448704
[TBL] [Abstract][Full Text] [Related]
6. Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.
Périgny M; Bairati I; Harvey I; Beauchemin M; Harel F; Plante M; Têtu B
Am J Clin Pathol; 2008 Feb; 129(2):226-31. PubMed ID: 18208802
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
Li LN; Zhou X; Gu Y; Yan J
Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer.
Sillanpää S; Anttila M; Suhonen K; Hämäläinen K; Turpeenniemi-Hujanen T; Puistola U; Tammi M; Sironen R; Saarikoski S; Kosma VM
Tumour Biol; 2007; 28(5):280-9. PubMed ID: 17962725
[TBL] [Abstract][Full Text] [Related]
9. The correlation between immunohistochemical expression of MMP-2 and the prognosis of epithelial ovarian cancer.
Ekinci T; Ozbay PO; Yiğit S; Yavuzcan A; Uysal S; Soylu F
Ginekol Pol; 2014 Feb; 85(2):121-30. PubMed ID: 24745158
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors.
Ozalp S; Tanir HM; Yalcin OT; Kabukcuoglu S; Oner U; Uray M
Eur J Gynaecol Oncol; 2003; 24(5):417-20. PubMed ID: 14584660
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies.
Lee JY; Myung SK; Song YS
Gynecol Oncol; 2013 Jun; 129(3):613-9. PubMed ID: 23422504
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of matrix metalloproteinase-2 expression in patients with epithelial ovarian tumor].
Wu X; Li H; Song J
Zhonghua Fu Chan Ke Za Zhi; 2001 Oct; 36(10):621-4. PubMed ID: 16134528
[TBL] [Abstract][Full Text] [Related]
15. Gelatinase A-immunoreactive protein in ovarian lesions- prognostic value in epithelial ovarian cancer.
Westerlund A; Apaja-Sarkkinen M; Höyhtyä M; Puistola U; Turpeenniemi-Hujanen T
Gynecol Oncol; 1999 Oct; 75(1):91-8. PubMed ID: 10502432
[TBL] [Abstract][Full Text] [Related]
16. Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies.
Gao J; Yang X; Zhang Y
Jpn J Clin Oncol; 2015 Jan; 45(1):49-60. PubMed ID: 25387732
[TBL] [Abstract][Full Text] [Related]
17. High Expression of Cullin7 Correlates with Unfavorable Prognosis in Epithelial Ovarian Cancer Patients.
Xi J; Zeng ST; Guo L; Feng J
Cancer Invest; 2016; 34(3):130-6. PubMed ID: 26962950
[TBL] [Abstract][Full Text] [Related]
18. Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis.
Bae HS; Kim HJ; Hong JH; Lee JK; Lee NW; Song JY
J Ovarian Res; 2014; 7():41. PubMed ID: 24834130
[TBL] [Abstract][Full Text] [Related]
19. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of matrix metalloproteinase-2 (MMP-2) in malignant ovarian epithelial tumours.
Kamel H; Abdelazim I; Habib SM; El Shourbagy MAA; Ahmed NS
J Obstet Gynaecol Can; 2010 Jun; 32(6):580-586. PubMed ID: 20569539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]